Clinical Nutrition Market size was valued at over USD 50.5 billion in 2022. Driven by the growing occurrence of metabolic disorders and numerous other chronic conditions worldwide, the market is expected to grow at over 10% CAGR from 2023 to 2032. ...
Active Pharmaceutical Ingredients Market size was valued at over USD 228.5 billion in 2022. Driven by the increasing prevalence of chronic diseases, the industry is estimated to expand at more than 6.5% CAGR from 2023 to 2032....
Allergic Rhinitis Drugs Market size was recorded at over USD 12 billion in 2022. Driven by consistent innovations in allergic rhinitis drugs, the industry is estimated to grow at more than 2.5% CAGR from 2023 to 2032....
Fabry Disease Treatment Market was valued at over USD 1.7 billion in 2021. Driven by the increasing burden of heart and other organ-related problems in late-onset Fabry disease patients, the industry is expected to depict a CAGR of over 8% from 2022 to 2030....
Nutricosmetics Market size was valued at nearly USD 6.9 billion in 2021. Driven by the growing awareness about hair and skin disorders, the industry is slated to depict a CAGR of 8.1% from 2022 to 2030....
Heparin Market size was worth over USD 4.8 billion in 2022. Driven by the high prevalence rate of chronic disorders globally, the industry could grow at over 2.5% CAGR from 2023 to 2032. ...
Pulmonary Arterial Hypertension (PAH) Market size exceeded USD 6.6 billion in 2020 and is anticipated to grow at a CAGR of 6% between 2021 and 2027. ...
Parkinson’s Disease Therapeutics Market valued at around USD 5.18 billion in 2020 and is projected to grow at more than 6.5% CAGR between 2021 and 2027....
Inhalation Anesthesia Market size was valued at USD 1.3 billion in 2018 and is expected to witness 5.4% CAGR from 2019 to 2025. In addition, the number of 250 ml bottles sold is set to exceed 15,500 units by 2025....
North America & Europe PEGylated Drugs Market size was valued over USD 7.7 billion in 2017 and is expected to witness more than 5% CAGR from 2018 to 2024....
The onco-nutrition and supplements market size projected to increase at a substantial rate during the forecast period of 2024 to 2032 owing to the rising prevalence of cancer and the ease of availability of advanced healthcare infrastructure....
The sleep disorders treatment drugs market size will expand at a commendable rate between 2024 and 2032 due to the rising awareness campaigns aimed at promoting healthy sleeping habits....
The preventive and therapeutic vaccine market size is poised to experience high growth by 2024-2032 due to introduction of new vaccines targeting a wider range of diseases, in tandem with expanding healthcare infrastructure....
The pharmaceutical robots market size is predicted to expand at a substantial rate between 2024 and 2032 due to the growing need for automated solutions in the pharmaceutical sector and the high costs associated with discovering new drugs. ...
The over-the-counter pain medication market size is projected to expand during 2023 to 2032, driven by the incidence of headache, neck & lower back pain, migraine, and other acute pain conditions is growing across the world....
The amino acid metabolism disorders treatment market size is expected to undergo considerable expansion between 2024 and 2032 owing to advancements in biotechnology and molecular genetics for improving the understanding of these disorders....
The novel drug delivery systems market size is expected to account for a considerable growth rate between 2024 and 2032 on account of the rising advancements in nanomedicine for more efficient and personalized drug delivery. ...
The chemotherapy-induced myelosuppression treatment market size is projected to expand at a prolific rate during the period 2024 to 2032, driven by increase in the overall expenditure on healthcare across the world....
The self-administered drugs market is poised to register significant growth by 2032 owing to the increasing incidences of chronic diseases worldwide....
The herbal medicinal products market size is estimated to grow at a significant rate during 2024 to 2032 due to the gradual shift away from conventional medicines and the growing burden of chronic diseases....
Human Recombinant Insulin Market size is projected to expand at a prolific rate during the period 2024 to 2032 on account of the escalating cases of diabetes and the imperative for insulin therapy....